Assessment of the Frequency and Contributing Factors for Major Infectious Diseases in UK Migrants: A Systematic Review - Top-Institutions - MDSpire

Assessment of the Frequency and Contributing Factors for Major Infectious Diseases in UK Migrants: A Systematic Review

  • By

  • Rebecca F. Baggaley

  • Carys M. Hooper

  • Luisa Silva

  • Zainab Lal

  • Paul Bird

  • Dee Menezes

  • Dominik Zenner

  • Christopher A. Martin

  • Manish Pareek

  • March 3, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    London School of Hygiene & Tropical Medicine
    London School of Hygiene & Tropical Medicine

    London, England

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Public Health
    • Migrant Health

  • #2

    University College London (UCL) Great Ormond Street Institute of Child Health
    University College London (UCL) Great Ormond Street Institute of Child Health

    London, England

    Key Differentiators

    • Infectious Diseases
    • Public Health
    • Epidemiology

  • #3

    Imperial College London
    Imperial College London

    London, England

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Global Health

  • #4

    University of Oxford, Nuffield Department of Medicine
    University of Oxford, Nuffield Department of Medicine

    Oxford, England

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Global Health

  • #5

    Public Health England (now UK Health Security Agency)
    Public Health England (now UK Health Security Agency)

    London, England

    Key Differentiators

    • Public Health
    • Infectious Disease Surveillance
    • Migrant Health

Original Source(s)

Assessment of the Frequency and Contributing Factors for Major Infectious Diseases in UK Migrants: A Systematic Review

  • by Rebecca F. Baggaley, Carys M. Hooper, Luisa Silva, Zainab Lal, Paul Bird, Dee Menezes, Dominik Zenner, Christopher A. Martin, Manish Pareek

  • March 3, 2026

Related Content

HHS Supports Repatriation of U.S. Citizens to Specialized Care Facilities

8 former CDC directors: Reform PEPFAR, don’t dismantle it

Two-Drug HIV Regimen Gains FDA Approval

Phase 3 trials showed noninferior viral suppression vs standard three-drug therapy with similar safety outcomes